ArticleGlobal epidemiology2025
Comparison of access to stroke diagnostics, treatment, rehabilitation, and outcome between men and women.
Article in Global epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Quality of life indicators among recent Ghanaian stroke survivors across 10 hospitals: A cross-sectional study.Equity neuroscience · 2026Article
- Predictors of Return to Work After Stroke in Hungary: A Mixed-Methods Economic and Clinical Data Analysis.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aimed to compare access to diagnostics, treatment, rehabilitation, and outcome in women and men with stroke. Methods: In this observational study we used routinely-collected, aggregate health data from all patients admitted with a stroke in the Capital Region and Region Zealand, Denmark from May 2016 until October 2022. Results: Among 28,855 stroke patients (55 % men, 45 % women), women were older (53 % women vs. 47 % men with age > 75 years). Overall, women had reduced access to: magnetic resonance imaging (MRI; 40 % vs. 43 %, CI 95 %: 1.06-1.16), computer tomography (CT)-angiography (25 % vs. 28 %, CI95%: 1.07-1.19), carotid ultrasound (48 % vs. 52 %, CI95%: 1.12-1.23), thrombolysis (16 % vs. 18 %, CI95%: 1.13-1.28), and neuropsychological assessment (9 % vs. 16 %, CI95%: 1.70-1.97). Home discharge rates were lower for women (45 % vs. 47 %, CI95%: 1.04-1.15), while in-hospital mortality was higher (8 % vs. 6 %, CI95%: 0.59-0.71). For patients >75 years, women had less access to MRI (34 % vs. 35 %, CI95%: 1-1.16), carotid ultrasound (46 % vs. 51 %, CI95%: 1.13-1.30), thrombolysis (15 % vs. 16 %, CI95%: 1.02-1.24), and neuropsychological assessment (2 % vs. 4 %, CI95%: 1.60-2.42). Women's in-hospital mortality remained higher also in patients >75 years (12 % vs. 8 %, CI95%: 0.62-0.79). Conclusions: Women had reduced access to testing, treatment, and rehabilitation across all age groups and stroke types. This disparity was most notable in interventions not included in the national quality assessment program.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.